High Level Abstraction (HLA) | Report 2020/02/27 |
---|
(1) (chemotherapy,colon,iii,resected) | 100.00 |
(2) (chemotherapy,colon,resection) | 84.24 |
(3) (adjuvant,chemotherapy,colon,risk) | 83.64 |
(4) (adjuvant,chemotherapy,colon,iii) | 82.34 |
(5) (chemotherapy,colon,tumor) | 76.46 |
(6) (adjuvant,chemotherapy,tumor) | 74.64 |
(7) (colon,preoperative) | 70.54 |
(8) (adjuvant,chemotherapy,colon,resected) | 67.55 |
(9) (adjuvant,tumor) | 65.78 |
(10) (clinicopathologic,colon,tumor) | 65.21 |
(11) (chemotherapy,colon,resected,risks) | 65.07 |
(12) (chemotherapy,treatment-related) | 64.95 |
(13) (chemotherapy,colon,resected,risk) | 63.19 |
(14) (adjuvant,treatment-related) | 62.71 |
(15) (adjuvant,chemotherapy,treatment-related) | 62.67 |
(16) (chemotherapy,clinicopathologic,colon,resected) | 60.91 |
(17) (chemotherapy,colon,postoperative) | 60.86 |
(18) (colon,iii,risk) | 60.06 |
(19) (chemotherapy,clinicopathologic,tumor) | 59.03 |
(20) (adjuvant,risk) | 58.52 |
(21) (adjuvant,chemotherapy,risk) | 58.48 |
(22) (chemotherapy,risk,tumor) | 58.02 |
(23) (adjuvant,colon,risk) | 57.97 |
(24) (chemotherapy,colon,risk) | 56.94 |
(25) (adjuvant,colon,resected,risk) | 56.69 |
(26) (adjuvant,colon,tumor) | 56.41 |
(27) (colon,risk,tumor) | 56.32 |
(28) (adjuvant,chemotherapy,colon,tumor) | 56.26 |
(29) (risk,tumor) | 55.50 |
(30) (chemotherapy,clinicopathologic,risk) | 54.50 |
(31) (adjuvant,clinicopathologic,colon) | 54.21 |
(32) (adjuvant,chemotherapy,clinicopathologic,colon) | 54.04 |
(33) (adjuvant,colon,treatment-related) | 53.72 |
(34) (chemotherapy,clinicopathologic,colon) | 53.71 |
(35) (adjuvant,chemotherapy,colon,treatment-related) | 53.58 |
(36) (clinicopathologic,colon,risk) | 53.23 |
(37) (chemotherapy,colon,treatment-related) | 53.11 |
(38) (clinicopathologic,risk) | 53.01 |
(39) (colon,colorectal,metastases) | 52.59 |
(40) (adjuvant,colon,iii) | 52.21 |
(41) (colon,iii,oxaliplatin,resected) | 51.09 |
(42) (resected,risk) | 44.98 |
(43) (colon,resected,risk) | 44.51 |
(44) (cancers,colon,oxaliplatin-based) | 43.83 |
(45) (chemotherapy,colon,oxaliplatin-based) | 43.50 |
(46) (colon,resection,risk) | 42.86 |
(47) (resection,risk) | 42.79 |
(48) (colon,diarrhea,iii,resected) | 42.15 |
(49) (adjuvant,colon,iii,resected) | 42.11 |
(50) (preoperative,resection) | 41.60 |
(51) (colon,metastases,tumor) | 41.20 |
(52) (adjuvant,chemotherapy,risks) | 40.80 |
(53) (neutropenia,resected) | 40.06 |
(54) (chemotherapy,colon,unresectable) | 39.46 |
(55) (colon,colorectal,preoperative,resection) | 38.58 |
(56) (colon,colorectal,metastases,resection) | 37.91 |
(57) (colon,postoperative,resection) | 37.45 |
(58) (colon,iii,oxaliplatin) | 36.87 |
(59) (colon,preoperative,resection) | 36.62 |
(60) (colon,oxaliplatin,resected) | 36.55 |
(61) (iii,oxaliplatin,resected) | 36.52 |
(62) (oxaliplatin,resected) | 36.51 |
(63) (adjuvant,chemotherapy,iii) | 36.38 |
(64) (colon,metastases,resection) | 36.18 |
(65) (colon,iii,neutropenia) | 36.03 |
(66) (colon,iii,neutropenia,resected) | 35.92 |
(67) (colon,neutropenia,resected) | 35.77 |
(68) (iii,neutropenia,resected) | 35.74 |
(69) (chemoradiotherapy,colon,resection) | 35.51 |
(70) (colon,iii,infusional) | 35.44 |
(71) (colon,iii,infusional,resected) | 35.33 |
(72) (iii,infusional,resected) | 35.25 |
(73) (colectomy,colon,resection) | 34.42 |
(74) (candidates,colon,resection) | 34.20 |
(75) (colon,fluorouracil,iii) | 33.86 |
(76) (chemotherapy,iii,resected) | 33.50 |
(77) (chemotherapy,mismatch,tumor) | 33.12 |
(78) (colon,colorectal,mismatch) | 32.97 |
(79) (chemotherapy,resected,risks) | 32.87 |
(80) (adjuvant,colon,risks) | 32.84 |
(81) (resection,tumor) | 32.78 |
(82) (adjuvant,chemotherapy,colon,risks) | 32.77 |
(83) (cancers,colon,colorectal) | 32.54 |
(84) (adjuvant,colon,resected,risks) | 32.35 |
(85) (colon,resected,risks) | 32.23 |
(86) (resected,risks) | 32.22 |
(87) (chemotherapy,resected,risk) | 32.01 |
(88) (colon,colorectal,nonpolyposis) | 31.82 |
(89) (colon,colorectal,metastatic) | 31.41 |
(90) (colon,rectal) | 31.18 |
(91) (colon,colorectal,markers) | 31.12 |
(92) (chemotherapy,clinicopathologic,resected) | 31.10 |
(93) (chemotherapy,resected,tumor-related) | 30.10 |
(94) (adjuvant,colon,resected,tumor-related) | 29.95 |
(95) (chemotherapy,resected,tumor) | 29.66 |
(96) (adjuvant,iii,resection) | 29.58 |
(97) (chemotherapy,colon,resected,tumor) | 29.38 |
(98) (bolus,colon,iii,resected) | 29.35 |
(99) (adjuvant,colon,resected,tumor) | 29.14 |
(100) (colon,metastases,preoperative) | 28.91 |
(101) (chemotherapy,resected,treatment-related) | 28.85 |
(102) (colorectal,tumor) | 28.83 |
(103) (chemotherapy,colon,resected,treatment-related) | 28.51 |
(104) (adjuvant,colon,resected,treatment-related) | 28.27 |
(105) (colon,mismatch,tumor) | 28.17 |
(106) (chemotherapy,colorectal,tumor) | 28.14 |
(107) (chemotherapy,resected,stratification) | 28.13 |
(108) (chemotherapy,colon,resected,stratification) | 28.11 |
(109) (chemotherapy,perineural,resected) | 27.96 |
(110) (chemotherapy,colon,perineural,resected) | 27.93 |
(111) (adjuvant,colon,perineural,resected) | 27.80 |
(112) (colorectal,metastases,tumor) | 27.76 |
(113) (cancers,colectomy,resection) | 27.38 |
(114) (cancers,colectomy,colon) | 27.32 |
(115) (arm,colon,iii,resected) | 27.22 |
(116) (chemoradiotherapy,chemotherapy) | 27.02 |
(117) (colon,geriatric,resected) | 26.57 |
(118) (adjuvant,iii,risk) | 26.40 |
(119) (chemotherapy,iii,risk) | 26.19 |
(120) (chemotherapy,colon,iii,risk) | 25.66 |
(121) (colorectal,metastases,resection) | 25.42 |
(122) (colon,iii,posttreatment) | 25.05 |
(123) (adjuvant,chemotherapy,preoperative) | 24.61 |
(124) (adjuvant,colon,preoperative) | 24.49 |
(125) (cancers,colon,preoperative) | 24.41 |
(126) (colon,colorectal,tumor) | 24.39 |
(127) (adjuvant,chemotherapy,colon,preoperative) | 24.33 |
(128) (colorectal,metastases,preoperative) | 24.24 |
(129) (colorectal,preoperative,resection) | 24.16 |
(130) (metastases,preoperative,resection) | 24.14 |
(131) (adjuvant,oxaliplatin-based) | 24.08 |
(132) (cancers,oxaliplatin-based) | 24.05 |
(133) (adjuvant,chemotherapy,oxaliplatin-based) | 24.03 |
(134) (colon,nodes,tumor) | 23.95 |
(135) (chemoradiotherapy,chemotherapy,resection) | 23.94 |
(136) (chemotherapy,colorectal,metastases) | 23.93 |
(137) (adjuvant,colon,oxaliplatin-based) | 23.92 |
(138) (adjuvant,chemotherapy,colon,oxaliplatin-based) | 23.75 |
(139) (chemoradiotherapy,resection) | 23.68 |
(140) (colon,metastasis,tumor) | 23.51 |
(141) (chemotherapy,metastases,tumor) | 23.49 |
(142) (chemotherapy,resection,tumor) | 23.15 |
(143) (adjuvant,chemotherapy,colon,volume) | 22.84 |
(144) (chemotherapy,colon,iii,oxaliplatin-containing) | 22.67 |
(145) (colon,lymphovascular,risk) | 22.64 |
(146) (chemotherapy,colon,iii,oxaliplatin) | 22.55 |
(147) (chemotherapy,colon,iii,neutropenia) | 22.26 |
(148) (colon,histology,risk) | 22.07 |
(149) (chemotherapy,colon,iii,intravenously) | 21.96 |
(150) (chemotherapy,colon,iii,infusional) | 21.84 |
(151) (chemotherapy,colon,fluorouracil,iii) | 21.60 |
(152) (chemotherapy,iii,tumor) | 21.50 |
(153) (chemotherapy,colon,fluoropyrimidines,iii) | 21.42 |
(154) (cancers,chemotherapy,colon) | 21.09 |
(155) (colorectal,palliation,resection) | 20.96 |
(156) (colorectal,national_comprehensive_cancer_network,resection) | 20.77 |
(157) (cancers,colon,resection) | 20.54 |
(158) (adjuvant,iii,postoperative) | 20.50 |
(159) (chemotherapy,postoperative,resection) | 20.43 |
(160) (chemotherapy,metastases,resection) | 20.43 |
(161) (chemotherapy,curative,resection) | 19.58 |
(162) (cancers,colon,nonobstructed) | 19.57 |
(163) (colon,resection,unresectable) | 19.53 |
(164) (colon,colorectal,preoperative) | 19.51 |
(165) (chemotherapy,colorectal,resection) | 18.90 |
(166) (colon,lesions,metastases) | 18.83 |
(167) (colon,colorectal,long-term) | 18.76 |
(168) (colon,colorectal,long-term,resection) | 18.68 |
(169) (colorectal,long-term,resection) | 18.60 |
(170) (colon,metastases,visualized) | 18.54 |
(171) (colon,colorectal,resection,visualized) | 18.51 |
(172) (colorectal,metastases,visualized) | 18.44 |
(173) (colon,colorectal,resection,tomography) | 18.41 |
(174) (colon,colorectal,pelvic,resection) | 18.34 |
(175) (colon,colorectal,palliation,resection) | 18.26 |
(176) (colorectal,manifestations,nonpolyposis) | 18.22 |
(177) (colon,colorectal,nontherapeutic,resection) | 18.16 |
(178) (colon,colorectal,national_comprehensive_cancer_network,resection) | 18.09 |
(179) (cancers,nonpolyposis) | 18.09 |
(180) (colon,colorectal,medical_oncology,resection) | 17.99 |
(181) (cancers,risk) | 17.96 |
(182) (cancers,colorectal,nonpolyposis) | 17.89 |
(183) (colon,resection,tumor) | 16.96 |
(184) (colorectal,manifestations) | 16.85 |
(185) (adjuvant,chemotherapy,resection) | 16.46 |
(186) (colon,colorectal,rectal) | 16.10 |
(187) (adjuvant,oxaliplatin) | 15.63 |
(188) (colon,colorectal,manifestations) | 15.45 |
(189) (adjuvant,colon,rectal) | 15.31 |
(190) (adjuvant,colon,rectal,resected) | 15.16 |
(191) (adjuvant,chemotherapy,resected) | 15.14 |
(192) (colon,rectal,resected) | 15.04 |
(193) (rectal,resected) | 15.03 |
(194) (adjuvant,colon,resected,transmural) | 14.90 |
(195) (bolus,colon,iii) | 14.82 |
(196) (bolus,colon,resected) | 14.76 |
(197) (bolus,resected) | 14.58 |
(198) (bolus,iii,resected) | 14.58 |
(199) (adjuvant,iii,oxaliplatin) | 14.54 |
(200) (diarrhea,resected) | 14.49 |